1996
DOI: 10.1080/02791072.1996.10472486
|View full text |Cite
|
Sign up to set email alerts
|

Improving Detoxification Outcomes from Methadone Maintenance Treatment: The Interrelationship of Affective States and Protracted Withdrawal

Abstract: Changing paradigms of health care and increasing knowledge of opioid addiction continue to influence the attitudes of the health profession toward methadone maintenance treatment (MMT). This approach has again reached the forefront of attention because of its significant role in reducing HIV transmission associated with intravenous drug use. In spite of the well-documented benefits of MMT, patients continue to detoxify from methadone for a variety of reasons both overt and covert. Variable outcomes and general… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
17
0
3

Year Published

1999
1999
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(21 citation statements)
references
References 72 publications
1
17
0
3
Order By: Relevance
“…Future prospective studies of personality pathology following detoxification from methadone would test this hypothesis. Moreover, the fact that elevated schizophrenia-spectrum traits are found in subjects 6-18 months after discontinuation from MMT suggests that methadone discontinuation may result in a protracted opiate withdrawal syndrome (42,43). Protracted withdrawal syndromes were also found in studies of phencyclidine (PCP) (44) and alcohol (45) addiction and may influence vulnerability to relapse.…”
Section: Discussionmentioning
confidence: 94%
“…Future prospective studies of personality pathology following detoxification from methadone would test this hypothesis. Moreover, the fact that elevated schizophrenia-spectrum traits are found in subjects 6-18 months after discontinuation from MMT suggests that methadone discontinuation may result in a protracted opiate withdrawal syndrome (42,43). Protracted withdrawal syndromes were also found in studies of phencyclidine (PCP) (44) and alcohol (45) addiction and may influence vulnerability to relapse.…”
Section: Discussionmentioning
confidence: 94%
“…Clients who receive MMT and remain in treatment show significant improvement in depressive symptoms (Rounsaville et al, 1982;Musselman and Kell, 1995;Dean et al, 2004). In contrast, during protracted abstinence from opiates, former heroin users are particularly prone to depressive states (Mason et al, 1998;Nunes et al, 2004), which may persist (Latowsky, 1996;Satel et al, 1993) and contribute to relapse (Gossop et al, 2002;Rao et al, 2004). Prior studies have not examined neural function related to depression in long-term opiate-abstinent and methadone-maintained, former heroin users.…”
Section: Introductionmentioning
confidence: 99%
“…Active addicts may be hindered by poor impulse control, planning, and decision-making (Grant et al, 2000;Lee and Pau, 2002;Bolla et al, 2003;Hill et al, 1979;Gritz et al, 1975;Chastain et al, 1986;Strang and Gurling, 1989;Guerra et al, 1987;Tapert, 1999;Franken et al, 2000), suggesting that opiate-induced cognitive impairment may contribute to the relapsing nature of addiction (Gossop et al, 2002;Latowsky, 1996;Rogers and Robbins, 2001;Teichner et al, 2002;Aharonovic et al, 2003). Little is known about the course of opiate-associated cognitive deficits after cessation of opiate use.…”
Section: Introductionmentioning
confidence: 99%